Trial intelligence / Profile preview

Vonoprazan Long-term Extension for Ulcer Prevention in Aspirin Users

NCT01456247Phase 3Completed

Sponsor
Takeda
Start
Mar 2012
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vonoprazan in gastric ulcer, duodenal ulcer, sponsored by Takeda. Started Mar 2012; status: completed.

02

Drugs

vonoprazan
03

Conditions

gastric ulcerduodenal ulcer

Beyond the preview

Go deeper on NCT01456247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01456247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call